STAT News
US · 11 mins ago
STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
Do you trust STAT News?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!